Illustration: Aïda Amer / Axios 

If there’s any area where the Trump administration and a Democratic House majority could find common ground, drug pricing may be it.

Why it matters: Pharma is on its heels, in a way it hasn’t been for years. And it will stay on the defensive for the next two years.

Be smart: President Trump has scrambled all the usual alliances.

  • On policy, Trump is basically aligned with Democrats, and congressional Republicans are in sync with industry.
  • Politically, Democrats aren’t inclined to help Trump notch a win on a critically important issue. And congressional Republicans are torn between their donors and their party’s most powerful leader.

Go deeper: These are the pharma companies hiking drug prices in 2019

Go deeper

8 mins ago - Technology

U.S. pushes homegrown drone industry amid China battle

Illustration: Sarah Grillo/Axios

Alarmed at the prospect of relying on Chinese-made drones for public safety and monitoring critical industries, U.S. investors and the federal government are newly backing a domestic drone industry of hardware and software companies.

The big picture: The moves come as the industry continues to be led by DJI, a Chinese hardware maker — and as concerns grow both in China and the U.S. about reliance on the other country's technology.

Exclusive: The N.Y. Times doubles down on TV and film ambitions

Illustration: Aïda Amer/Axios

One of the country's oldest and most established media companies is starting to look more like a Hollywood studio than a traditional newspaper.

Driving the news: The New York Times has 10 scripted TV show projects in development, as well as 3 feature documentaries coming out this year and several other documentary projects in development and production, executives tell Axios.

Electric vehicle companies are reeling in cash without producing a car

Illustration: Sarah Grillo/Axios

These are heady days for electric vehicle companies, with a lack of actual car production becoming a popular norm.

Why it matters: The capital infusion is the latest in a busy stretch of deals and market moves that suggest private investors and equity markets see big potential in technologies that now represent a tiny slice of the global vehicle fleet.